Header Logo

Connection

WOLFGANG WINKELMAYER to Drug Approval

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Drug Approval.
WOLFGANG WINKELMAYER
Connection Strength
0.114
Drug Approval
  1. The prevalence and cost of unapproved uses of top-selling orphan drugs. PLoS One. 2012; 7(2):e31894.
    View in: PubMed
    Score: 0.097
  2. Surrogate markers in clinical studies: problems solved or created? Am J Kidney Dis. 2006 Jul; 48(1):159-66.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.